Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation (Q64140189)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation |
clinical trial |
Statements
Effects of Sympathicomimetic Agonists on the Disease Course and Mutant Allele Burden in Patients With JAK2-mutated Myeloproliferative Neoplasms. A Multicenter Phase II Trial. (English)
0 references
April 2015
0 references
December 2016
0 references
39
0 references
18 year
0 references